about
Characterization of heat shock protein-specific T cells in atherosclerosis.A comparison of Er:YAG laser and mechanical debridement for the non-surgical treatment of chronic periodontitis: a randomized, prospective clinical study.The influence of a triclosan toothpaste on adverse events in patients with cardiovascular disease over 5-years.Relationship between periodontal infections and systemic disease.Periodontopathogen levels following the use of an Er:YAG laser in the treatment of chronic periodontitis.Oral infections and systemic disease--an emerging problem in medicine.The oral microbiome of patients with axial spondyloarthritis compared to healthy individuals.Immediate restoration/loading of immediately placed single implants: is it an effective bimodal approach?Periodontal disease and systemic health: current status.Dental stem cells and their potential role in apexogenesis and apexification.Comparison of the clinical features of chronic and aggressive periodontitis.Histopathological features of chronic and aggressive periodontitis.Why should a doctor be interested in oral disease?Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis.Periodontitis among adult populations in the Arab World.Periodontal disease and systemic illness: will the evidence ever be enough?An overview of systematic reviews of the use of systemic antimicrobials for the treatment of periodontitis.Natural history of periodontitis: Disease progression and tooth loss over 40 years.An overview of systematic reviews on the effectiveness of periodontal treatment to improve glycaemic control.Risk factors that may modify the innate and adaptive immune responses in periodontal diseases.Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease.The proportion of interleukin-4, interferon-gamma and interleukin-10-positive cells in Porphyromonas gingivalis--specific T-cell lines established from P. gingivalis-positive subjects.Antigen-specific T-cell receptor V beta expression in Porphyromonas gingivalis-specific T-cell lines.The Influence of Triclosan on Biomarkers of Cardiovascular Risk in Patients in the Cardiovascular and Periodontal Study (CAPS): A Randomized Controlled Trial.Diabetes, periodontitis, and the subgingival microbiota.Experiences and perceptions of oral health and oral health care among a sample of older New Zealanders.Long term use of triclosan toothpaste and thyroid function.Periodontal diseases in an Omani adult population: a preliminary study.Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella intermedia over a 5-year period: effect of a triclosan/copolymer dentifrice.Analysis of P. gingivalis, T. forsythia and S. aureus levels in edentulous mouths prior to and 6 months after placement of one-piece zirconia and titanium implants.Radiographic study of ethnic variation in alveolar bone height among New Zealand dental students.Heat shock proteins: a double-edged sword linking periodontal and cardiovascular diseases.Effects of environmental tobacco smoke on the oral health of preschool children.Feasibility of the salivary transcriptome as a novel biomarker in determining disease susceptibility.Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblasts.No evidence of triclosan-resistant bacteria following long-term use of triclosan-containing toothpaste.VEGF and VEGFR2 in dentigerous cysts associated with impacted third molars.A comparison of salivary IgA in children with Down syndrome and their family members.
P50
Q33859286-A60FD690-10F2-4676-A441-ADD6DCBECDF6Q34225380-96E00783-76FF-46F8-96CB-A8CAB8092DA7Q34450517-7A658DCD-803D-414A-9A8E-A57E69F78248Q34666891-1A1DE857-5563-48FD-9101-B317C4FA6995Q35550831-47590700-525F-4AD8-9C6C-1BFD97B04D58Q36917174-60588E08-33AB-4C48-8E2C-9BB237A032FAQ37001078-685279B7-934E-48B8-903C-8DE74F64636CQ37514400-22F00A88-9F83-48C0-9D4C-9A3B6F754A6DQ37593647-D3ACFBC1-4772-467D-ACBE-5BB43D0104B9Q37613755-F7743122-1F31-4920-8848-836F644D47FDQ37733759-EAE8608C-E0BD-4E7D-A621-7F9C13BE7C0FQ37733763-166191FB-0FF2-4B66-8E10-80A78B03D59EQ37799367-F867F7C3-328E-4637-8968-1B76140BF843Q37864190-346A0A05-56C3-49A1-BF7B-868B9FD40401Q38081509-25637817-B956-4CB1-8973-CC9C1AC9EF9AQ38097947-C1C9F17B-0BBC-44F4-8B60-E4DA3E6227C5Q38262451-0947B76E-C870-44C3-BBCA-FF5ABDF1F1AEQ38666984-AF3C9842-6879-458B-909F-B0A895403BF4Q38749416-E7F4AEBF-56D3-483C-9E02-4AF66B7D5BC4Q38798338-52F596EB-B69F-4C7B-8732-AC84B584BE75Q38957935-2103C966-1361-4960-AC3A-541D133E8D0BQ39981949-7D459F96-7486-434A-8F0C-82D554F6CEDAQ40919406-8E12C803-E136-4441-9C2D-047D8184D114Q40984920-A6B78912-FAD2-43D1-A162-956DC4F519E2Q41291516-019625EA-C291-4CAF-8C64-602E33A9BF28Q41790796-5DAD19CB-D295-48E0-BC4B-B493D11ED6BBQ42667016-2DA1D2DE-364D-4014-B097-27E070048283Q43588848-E6DD8A4C-4D8F-4DE8-A2DA-7160E1665F3AQ44179735-2D56EC9F-9ED8-4A9D-A2A4-AE705B5EAFF6Q44471273-2F07C964-E12D-4645-AA13-E677E347E662Q46795954-85CBC025-4E36-4630-A02A-156B045C4AB7Q47285633-0A63EDAE-7EA2-40E6-84AB-01D8550C0C47Q47625278-737FA1DE-ECAA-43E7-9705-58F49EC8AEE0Q47678611-1D4295ED-F3AD-4FFE-AB53-CC52E9BE776AQ48346013-B325A241-9C7D-4ACB-ABE9-209202C2C59CQ48969740-23811316-D7B2-4F6B-AB2A-010C45DE333DQ50206496-AD31CD27-7829-4FC7-BA55-0B7E34858699Q50491174-FFDBCDC9-8348-48F4-A2D2-0C27DB004A65Q50896941-5EA173D3-E348-47CD-80B9-AC0B09C6E5ACQ53967991-0537E75B-C47F-4685-9820-E6694FF05B2A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-0423-1581
@en
name
Mary P Cullinan
@ast
Mary P Cullinan
@en
Mary P Cullinan
@es
Mary P Cullinan
@nl
type
label
Mary P Cullinan
@ast
Mary P Cullinan
@en
Mary P Cullinan
@es
Mary P Cullinan
@nl
prefLabel
Mary P Cullinan
@ast
Mary P Cullinan
@en
Mary P Cullinan
@es
Mary P Cullinan
@nl
P106
P1153
7004069335
P21
P31
P496
0000-0002-0423-1581